These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8640117)

  • 1. [Functional transformation of cytotoxic T-lymphocytes into T-suppressors under the effect of major histocompatibility class I antigens and thymus hormone].
    Anfalova TV; Galaktionov VG
    Dokl Akad Nauk; 1995 Dec; 345(5):701-3. PubMed ID: 8640117
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional transformation of cytotoxic lymphocytes into T-suppressors under the influence of two mediators.
    Anfalova TV; Galaktionov VG; Brondz BD
    Immunol Lett; 1997 Nov; 59(2):121-6. PubMed ID: 9373221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reactive gamma delta T cells are eliminated in the thymus.
    Dent AL; Matis LA; Hooshmand F; Widacki SM; Bluestone JA; Hedrick SM
    Nature; 1990 Feb; 343(6260):714-9. PubMed ID: 1968227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The formation of T-suppressors that suppress the activity of alloreactive T-cells after lymphocyte interaction with 2 different thymus-derived mediators].
    Anfalova TV; Lutsan NI
    Ontogenez; 1993; 24(2):76-82. PubMed ID: 8488015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of suppressor activity in allospecific cytotoxic T-lymphocytes].
    Anfalova TV; Galaktionov VG; Brondz BD
    Mol Biol (Mosk); 1997; 31(1):124-9. PubMed ID: 9173231
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of immune escape of cancer and its regulation.
    Morita R; Hirohashi Y; Torigoe T
    Rinsho Ketsueki; 2009 May; 50(5):375-80. PubMed ID: 19483397
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunogenicity of class I+, class II- hepatocytes.
    Almond PS; Bumgardner GL; Chen S; Platt J; Payne WD; Matas AJ
    Transplant Proc; 1991 Feb; 23(1 Pt 1):108-9. PubMed ID: 1899298
    [No Abstract]   [Full Text] [Related]  

  • 8. Tolerogenic ability of thymocytes in organ-cultured thymus lobes.
    Matsuhashi N; Kawase Y; Suzuki G
    J Immunol; 1991 Jan; 146(2):444-8. PubMed ID: 1670942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Features of inducing cytotoxic T-lymphocytes, specific for a class I major histocompatibility molecule upon immunization into the foot pad].
    Azhipa OIa; Brondz BD
    Biull Eksp Biol Med; 1995 Feb; 119(2):190-3. PubMed ID: 7670050
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunologic characterization of CD7-deficient mice.
    Lee DM; Staats HF; Sundy JS; Patel DD; Sempowski GD; Scearce RM; Jones DM; Haynes BF
    J Immunol; 1998 Jun; 160(12):5749-56. PubMed ID: 9637484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell activation. VI. Inhibitory and stimulatory effects of anti-major histocompatibility complex class I antibodies in allogeneic mixed lymphocyte culture.
    Röpke M; Röpke C; Claësson MH
    Immunology; 1993 Jun; 79(2):263-9. PubMed ID: 8344704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral tolerance mechanisms prevent the development of autoreactive T cells in chimeras grafted with two minor incompatible thymuses.
    Zamoyska R; Waldmann H; Matzinger P
    Eur J Immunol; 1989 Jan; 19(1):111-7. PubMed ID: 2522046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for involvement of clonal anergy in MHC class I and class II disparate skin allograft tolerance after the termination of intrathymic clonal deletion.
    Tomita Y; Nishimura Y; Harada N; Eto M; Ayukawa K; Yoshikai Y; Nomoto K
    J Immunol; 1990 Dec; 145(12):4026-36. PubMed ID: 2147933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N; Fontaine P; Perreault C
    Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the cytotoxic T lymphocyte response against Qa-1 alloantigens.
    Cassell DJ; Forman J
    J Immunol; 1990 Jun; 144(11):4075-81. PubMed ID: 2140385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The functional capacity of thymus subpopulations: limit-dilution analysis of all precursors of cytotoxic lymphocytes and of all T cells capable of proliferation in subpopulations separated by the use of peanut agglutinin.
    Wei-Feng C; Scollay R; Shortman K
    J Immunol; 1982 Jul; 129(1):18-24. PubMed ID: 6211480
    [No Abstract]   [Full Text] [Related]  

  • 17. Selective cytotoxic T-lymphocyte targeting of tumor immune escape variants.
    van Hall T; Wolpert EZ; van Veelen P; Laban S; van der Veer M; Roseboom M; Bres S; Grufman P; de Ru A; Meiring H; de Jong A; Franken K; Teixeira A; Valentijn R; Drijfhout JW; Koning F; Camps M; Ossendorp F; Kärre K; Ljunggren HG; Melief CJ; Offringa R
    Nat Med; 2006 Apr; 12(4):417-24. PubMed ID: 16550190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class I restricted interaction between suppressor and cytolytic cells in the response to minor histocompatibility antigens.
    Rammensee HG; Juretic A; Nagy ZA; Klein J
    J Immunol; 1984 Feb; 132(2):668-72. PubMed ID: 6197473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones.
    Koide J; Engleman EG
    J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of purified HLA class I molecules with alloreactive CTL.
    Hausmann R; Zavazava N; Müller-Ruchholtz W
    Transplant Proc; 1991 Aug; 23(4):2255-7. PubMed ID: 1871864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.